Track Abbott Laboratories — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Abbott Laboratories ABT.SW Open Abbott Laboratories in new tab

84.50 CHF
P/E
30.29
EPS
2.79
Yield
3.03%
Safety Score
82
P/B
3.62
ROE
12.33
Beta
0.65
Loading chart...
Key Metrics
Earnings dateJuly 16, 2026
P/E30.29
EPS2.79
Book Value23.34
Price to Book3.62
Debt/Equity64.77
% Insiders0.494%
Growth
Revenue Growth0.08%
Earnings Growth-0.20%
Dividend
Dividend Yield3.03%
Annual dividends1.97 CHF
Ex-Div. DateApril 15, 2026
Payout67.23%
5y avg Yield1.87%

DCF Valuation

Tweak assumptions to recompute fair value for Abbott Laboratories (ABT.SW)
Currency: CHF
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Abbott Laboratories Logo Abbott Laboratories Analysis (ABT.SW)

United States Health Care Official Website Stock

Is Abbott Laboratories a good investment? Abbott Laboratories (ABT.SW) is currently trading at 84.50 CHF.

In terms of valuation, the stock trades at a P/E ratio of 30.29. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Abbott Laboratories is expected to release its next earnings report on July 16, 2026.

For income investors, Abbott Laboratories pays a dividend yield of 3.03%. With a payout ratio of 67%, the dividend appears sustainable.

Investor FAQ

Does Abbott Laboratories pay a dividend?

Yes, it pays an annual dividend of 1.97 CHF (3.03% yield).

What asset class is Abbott Laboratories?

Abbott Laboratories is classified as a Stock. You can compare it against 12 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be July 16, 2026. The company currently has a trailing EPS of 2.79.

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Exchange Ticker
GER (Germany) ABL.DE
BUE (Argentina) ABT.BA
SGO (Chile) ABT.SN
SGO (Chile) ABTCL.SN
NYQ (United States) ABT
EBS (Ireland) ABT.SW
MIL (Italy) ABT.MI
FRA (Germany) ABL.F
STU (Germany) ABL.SG
MEX (Mexico) ABT.MX
VIE (Austria) ABT.VI
SAO (Brazil) ABTT34.SA
Dividend Yield

3.03% (5y avg: 1.87%)

Annual Dividends

1.97 CHF

Next ex. div date

April 15, 2026

Payout Ratio

67.23%

Historical Dividends
Year Total Dividends
2027 0.55 CHF
2026 2.04 CHF
2025 1.97 CHF
2024 1.94 CHF
2023 1.83 CHF
2022 1.80 CHF
2021 1.64 CHF
2020 1.36 CHF
2019 1.27 CHF
2018 1.10 CHF
2017 1.05 CHF

Yearly aggregated dividends

Dividends

Abbott Laboratories
May 15, 2026 Paid
Dividend
0.49521 CHF
Abbott Laboratories
Feb 13, 2026 Paid
Dividend
0.50623 CHF
Abbott Laboratories
Nov 17, 2025 Paid
Dividend
0.47023 CHF
Abbott Laboratories
Aug 15, 2025 Paid
Dividend
0.47371 CHF

Historical Split Corporate Actions

Split Date Split Ratio to 1
Jan. 3, 2013 2.000000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion